TY  - GEN
AU  - Smith,C H
AU  - Jackson,K
AU  - Bashir,S J
AU  - Perez,A
AU  - Chew,A L
AU  - Powell,A M
AU  - Wain,M
AU  - Barker,J N W N
TI  - Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study
SN  - 0007-0963
PY  - 2006///1017
KW  - Abscess
KW  - etiology
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Autoantibodies
KW  - blood
KW  - Carcinoma, Basal Cell
KW  - Carcinoma, Renal Cell
KW  - Cellulitis
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Hypertension
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Kidney Neoplasms
KW  - Lentigo
KW  - Liver Diseases
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Psoriasis
KW  - drug therapy
KW  - Respiratory Tract Infections
KW  - Skin Neoplasms
KW  - Thrombocytopenia
KW  - Time Factors
KW  - Treatment Outcome
KW  - Tuberculosis
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/j.1365-2133.2006.07316.x
ER  -